LifeVantage Announces Positive In Vitro Results for Novel GLP-1 System Demonstrating Synergistic Gene Activation for Improved Weight Management* † Page 1

Recent findings reveal how LifeVantage’s two-product system activates GLP-1 production through targeted gene expression and microbiome support*

SALT LAKE CITY, September 10, 2024 (GLOBE NEWSWIRE) — LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, is pleased to announce promising results from an in vitro study examining the combined effects of its upcoming two-product system on the activation of GLP-1 production.*